Press area
17 May 2022

The hospital of the future in a needle: Teoresi as a partner of the Nanocan project for in vivo theranostics in oncology

Life Sciences

From the virtuous collaboration between academic and industrial research, Nanocan was born, the starting point to develop the Hospital in a Needle: a new class of devices that integrate platforms for diagnosis and therapy (theranostics) to be employed in oncology, using optical fibers integrated in medical needles. Teoresi, as a technical partner of Nanocan, provides its engineering competencies to develop these innovative platforms.